-transparent.png){kind=logo}
Cefixime was 8 to 10 times more active than cefaclor and augmentin against isolates of Escherichia coli, Klebsiella pneumoniae and Salmonella typhi, MIC90 values ranging from 0.06 to 0.25 micrograms/ml. However, none of these three drugs was particularly active against isolates of more resistant gram-negative bacilli such as Enterobacter, Serratia, Citrobacter, Acinetobacter, Providencia and Achromobacter spp. The lowest MIC values for gram-negative bacilli were seen with ciprofloxacin, except for isolates of Acinetobacter, where cotrimoxazole was the most active of the five drugs studied. Augmentin and ciprofloxacin exhibited the lowest MICs for isolates of streptococci and corynebacteria. Although cefixime may be among the most active oral beta-lactam drugs, it does not appear to be useful for treatment of infections caused by more resistant gram-negative bacilli.
G W Counts, and
L K Baugher, and
B K Ulness, and
D J Hamilton
December 1988,
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
G W Counts, and
L K Baugher, and
B K Ulness, and
D J Hamilton
October 1987,
The Pediatric infectious disease journal,
G W Counts, and
L K Baugher, and
B K Ulness, and
D J Hamilton
April 1987,
European journal of clinical microbiology,
G W Counts, and
L K Baugher, and
B K Ulness, and
D J Hamilton
January 1994,
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
G W Counts, and
L K Baugher, and
B K Ulness, and
D J Hamilton
January 1987,
Journal of clinical pharmacology,
G W Counts, and
L K Baugher, and
B K Ulness, and
D J Hamilton
June 1992,
Journal of chemotherapy (Florence, Italy),
G W Counts, and
L K Baugher, and
B K Ulness, and
D J Hamilton
June 1989,
Pathologie-biologie,
G W Counts, and
L K Baugher, and
B K Ulness, and
D J Hamilton
February 1987,
Pharmaceutical research,
G W Counts, and
L K Baugher, and
B K Ulness, and
D J Hamilton
October 1989,
Presse medicale (Paris, France : 1983),
G W Counts, and
L K Baugher, and
B K Ulness, and
D J Hamilton
October 1989,
Antimicrobial agents and chemotherapy,
